For the quarter ending 2026-03-31, BMEA had -$11,119K decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -12,415 | 4,612 | -16,407 | -50,002 |
| Depreciation expense | 46 | 47 | 427 | 935 |
| Non-cash operating lease expense | - | 173 | 117 | 1,557 |
| Stock-based compensation expense | 1,582 | 1,838 | 1,940 | 5,742 |
| Change in fair value of warrant liability | 581 | -15,758 | -3,872 | -227 |
| Impairment of long-lived assets | - | 0 | 2,205 | - |
| Gain on sale of property and equipment | 510 | - | - | - |
| Prepaid expenses and other current assets | -982 | -560 | -5,641 | -1,614 |
| Other assets | - | - | -4 | -615 |
| Other non-current assets | - | -619 | - | - |
| Accounts payable | 1,380 | -3,169 | -1,828 | -4,703 |
| Accrued expenses and other current liabilities | -2,965 | -1,963 | 400 | 1,308 |
| Operating lease liabilities | -350 | -282 | -177 | -1,718 |
| Net cash used in operating activities | -11,669 | -13,942 | -11,550 | -44,879 |
| Purchase of property and equipment | - | - | 0 | 0 |
| Proceeds from sale of property and equipment | 550 | - | - | - |
| Net cash provided by investing activities | 550 | - | 0 | 0 |
| Proceeds from issuance of common stock under at the market equity offering program, net of offering costs | - | -124 | 0 | 5,032 |
| Proceeds from issuance of common stock, common warrants and pre-funded warrants from public offerings | - | - | 2,596 | 37,800 |
| Payments of financing costs | - | - | 628 | 125 |
| Proceeds from issuance of common stock, common warrants and pre-funded warrants, net of offering costs | - | 62,837 | - | - |
| Proceeds from stock options exercised and purchases under the employee stock purchase plan | - | 42 | 0 | 117 |
| Net cash provided by financing activities | - | 23,112 | 1,968 | 42,824 |
| Net decrease in cash, cash equivalents, and restricted cash | -11,119 | 9,170 | -9,582 | -2,055 |
| Cash, cash equivalents, and restricted cash at the beginning of the period | 56,181 | 47,011 | 58,648 | - |
| Cash, cash equivalents, and restricted cash at the end of the period | 45,062 | 56,181 | 47,011 | - |
Biomea Fusion, Inc. (BMEA)
Biomea Fusion, Inc. (BMEA)